Triaminic Infant Oral Decongestant Drug Information [ Novartis ]
Table of content
Triaminic Infant Oral Decongestant category:
- Human
- Alpha- and Beta-Adrenergic Agonists
- Other Nonsteroidal Antiimflammatory Agents
- Sympathomimetic Adrenergic Agents
Active ingredients:
Triaminic Infant Oral Decongestant companies and manufacturers:
General Information
Triaminic Infant Oral Decongestant forms, composition and dosages:
- Drops; Oral; Pseudoephedrine Hydrochloride
Indications, usages and classification codes:
- R01BA02 - Pseudoephedrine
PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
- Congestion Relief Watson Pharmaceuticals
- Contac Cold Nondrowsy GlaxoSmithKline
- Contac Non Drowsy GlaxoSmithKline
- Contac Non Drowsy 12 Hour Relief GlaxoSmithKline
- Contac-C Nondrowsy GlaxoSmithKline
- Decofed Alpharma; The Harvard Drug Group
- Decon N S Jaapharm Canada
- Decongestant Tablets Boots
- Decongestant Tablets Stanley Pharmaceuticals
- Decongestant Tablets Unichem, United Kingdom
- Decorin Novartis
- DeFed Ferndale Laboratories
- Dexan Recalcine Laboratorios
- Dimetapp Daytime Wyeth
- Dimetapp Decongestant Wyeth
- Dimetapp Decongestant Infant Drops Wyeth
- Dimetapp Decongestant Pediatric Drops Wyeth
- Dimetapp Sinus Wyeth
- Dorcol Children's Decongestant Novartis
- Drilix Be-Tabs Pharmaceuticals
